Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype

References

Brookman-May, S.D., May, M., Wolff, I., Zigeuner, R., Hutterer, G.C., Cindolo, L., Schips, L., De Cobelli, O., Rocco, B., De Nunzio, C., et al. (2015). Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors? Eur. Urol. 67, 943–951.10.1016/j.eururo.2014.11.055Suche in Google Scholar PubMed

Chen, Y., Sun, Y., Rao, Q., Xu, H., Li, L., and Chang, C. (2015). Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status. Oncotarget 6, 31203–31215.10.18632/oncotarget.4522Suche in Google Scholar PubMed PubMed Central

Cui, S.Y., Wang, R., and Chen, L.B. (2014). MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J. Cell Mol. Med. 18, 1913–1926.10.1111/jcmm.12358Suche in Google Scholar PubMed PubMed Central

Doberstein, K., Steinmeyer, N., Hartmetz, A.K., Eberhardt, W., Mittelbronn, M., Harter, P.N., Juengel, E., Blaheta, R., Pfeilschifter, J., and Gutwein, P. (2013). MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia 15, 218–230.10.1593/neo.121222Suche in Google Scholar PubMed PubMed Central

Eble, J.N., Sauter, G., Epstein, J.I., and Sesterhenn, I.A. (2004). World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs (Lyon, France: IARC Press).Suche in Google Scholar

Escudier, B., Porta, C., Schmidinger, M., Algaba, F., Patard, J.J., Khoo, V., Eisen, T., and Horwich, A.; ESMO Guidelines Working Group. (2014). Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25 (Suppl 3), iii49–iii56.10.1093/annonc/mdu259Suche in Google Scholar PubMed

Faragalla, H., Youssef, Y.M., Scorilas, A., Khalil, B., White, N.M., Mejia-Guerrero, S., Khella, H., Jewett, M.A., Evans, A., Lichner, Z., et al. (2012). The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J. Mol. Diagn. 14, 385–392.10.1016/j.jmoldx.2012.02.003Suche in Google Scholar PubMed

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W., Comber, H., Forman, D., and Bray, F. (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer 49, 1374–1403.10.1016/j.ejca.2012.12.027Suche in Google Scholar PubMed

Fuhrman, S.A., Lasky, L.C., and Limas, C. (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6, 655–663.10.1097/00000478-198210000-00007Suche in Google Scholar PubMed

Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M., Hu, J., Jiang, S., Fletcher-Sananikone, E., Zhuang, L., et al. (2010). FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. Cancer Cell 18, 472–484.10.1016/j.ccr.2010.10.019Suche in Google Scholar PubMed PubMed Central

Ha, M. and Kim, V.N. (2014). Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15, 509–524.10.1038/nrm3838Suche in Google Scholar PubMed

Hanley, J.A. and McNeil, B.J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29–36.10.1148/radiology.143.1.7063747Suche in Google Scholar PubMed

Hayes, J., Peruzzi, P.P., and Lawler, S. (2014). MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20, 460–449.10.1016/j.molmed.2014.06.005Suche in Google Scholar PubMed

Jonas, S. and Izaurralde, E. (2015). Towards a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 16, 421–433.10.1038/nrg3965Suche in Google Scholar PubMed

Jonckheere, A.R. (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41, 133–145.10.1093/biomet/41.1-2.133Suche in Google Scholar

Juan, D., Alexe, G., Antes, T., Liu, H., Madabhushi, A., Delisi, C., Ganesan, S., Bhanot, G., and Liou, L.S. (2010). Identification of a microRNA panel for clear-cell kidney cancer. Urology 75, 835–841.10.1016/j.urology.2009.10.033Suche in Google Scholar PubMed

Khella, H.W., Bakhet, M., Allo, G., Jewett, M.A., Girgis, A.H., Latif, A., Girgis, H., Von Both, I., Bjarnason, G.A., and Yousef, G.M. (2013). miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis 34, 2231–2239.10.1093/carcin/bgt184Suche in Google Scholar PubMed

Khella, H.W., Butz, H., Ding, Q., Rotondo, F., Evans, K.R., Kupchak, P., Dharsee, M., Latif, A., Pasic, M.D., Lianidou, E., et al. (2015). miR-221/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma. Mol. Ther. 23, 1748–1758.10.1038/mt.2015.129Suche in Google Scholar PubMed PubMed Central

Kruskal, W. H. and Wallis, W. A. (1952). Use of ranks in one-criterion variance analysis. J. Am. Statist. Assoc. 47, 583–621.10.1080/01621459.1952.10483441Suche in Google Scholar

Li, M., Wang, Y., Song, Y., Bu, R., Yin, B., Fei, X., Guo, Q., and Wu, B. (2015). MicroRNAs in renal cell carcinoma: a systematic review of clinical implications. Oncol. Rep. 33, 1571–1578.10.3892/or.2015.3799Suche in Google Scholar PubMed PubMed Central

Livak, K.J. and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods 25, 402–408.10.1006/meth.2001.1262Suche in Google Scholar PubMed

Ljungberg, B., Bensalah, K., Bex, A., Canfield, S., Dabestani, S., Giles, R.H., Hofmann, F., Hora, M., Kuczyk, M.A., Lam, T., et al. (2015). Guidelines on Renal Cell Carcinoma. Available at: http://uroweb.org/guideline/renal-cell-carcinoma/. Accessed: July 2015.10.1016/j.eururo.2015.01.005Suche in Google Scholar

Lu, R., Ji, Z., Li, X., Zhai, Q., Zhao, C., Jiang, Z., Zhang, S., Nie, L., and Yu, Z. (2014). miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J. Cancer Res. Clin. Oncol. 140, 387–397.10.1007/s00432-013-1577-zSuche in Google Scholar PubMed

Mann, H.B. and Whitney, D.R. (1947). On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18, 50–60.10.1214/aoms/1177730491Suche in Google Scholar

Maroto, P. and Rini, B. (2014). Molecular biomarkers in advanced renal cell carcinoma. Clin. Cancer Res. 20, 2060–2071.10.1158/1078-0432.CCR-13-1351Suche in Google Scholar PubMed

Motzer, R.J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G.B., Chang, S.S., Choueiri, T.K., Costello, B.A., Derweesh, I.H., et al. (2015). Kidney cancer, version 3.2015. J. Natl. Compr. Canc. Netw. 13, 151–159.10.6004/jnccn.2015.0022Suche in Google Scholar PubMed

Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L.T., Hijiya, N., Uchida, T., Sato, F., et al. (2008). Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J. Pathol. 216, 418–427.10.1002/path.2437Suche in Google Scholar PubMed

Rioux-Leclercq, N., Karakiewicz, P.I., Trinh, Q.D., Ficarra, V., Cindolo, L., de la Taille, A., Tostain, J., Zigeuner, R., Mejean, A., and Patard, J.J. (2007). Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 109, 868–874.10.1002/cncr.22463Suche in Google Scholar PubMed

Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K., and Mo, Y.Y. (2009). p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. USA 106, 3207–3212.10.1073/pnas.0808042106Suche in Google Scholar PubMed PubMed Central

Sachdeva, M., Liu, Q., Cao, J., Lu, Z., and Mo, Y.Y. (2012). Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells. Nucleic Acids Res. 40, 6683–6692.10.1093/nar/gks324Suche in Google Scholar PubMed PubMed Central

Shi, R. and Chiang, V.L. (2005). Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39, 519–525.10.2144/000112010Suche in Google Scholar PubMed

Siegel, R.L., Miller, K.D., and Jemal, A. (2015). Cancer statistics, 2015. CA Cancer J. Clin. 65, 5–29.10.3322/caac.21254Suche in Google Scholar PubMed

Slaby, O., Redova, M., Poprach, A., Nekvindova, J., Iliev, R., Radova, L., Lakomy, R., Svoboda, M., and Vyzula, R. (2012). Identification of microRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer 51, 707–716.10.1002/gcc.21957Suche in Google Scholar PubMed

Sobin, L.H., Gospodariwicz, M.K., and Wittekind, C. (2009). TNM Classification of Malignant Tumours (Hoboken, NJ, USA: Wiley-Blackwell).10.1002/9780471420194.tnmc26Suche in Google Scholar

Wach, S., Nolte, E., Theil, A., Stöhr, C., T. Rau, T., Hartmann, A., Ekici, A., Keck, B., Taubert, H., and Wullich, B. (2013). MicroRNA profiles classify papillary renal cell carcinoma subtypes. Br. J. Cancer 109, 714–722.10.1038/bjc.2013.313Suche in Google Scholar PubMed PubMed Central

White, N.M., Khella, H.W., Grigull, J., Adzovic, S., Youssef, Y.M., Honey, R.J., Stewart, R., Pace, K.T., Bjarnason, G.A., Jewett, M.A., et al. (2011). miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br. J. Cancer 105, 1741–1749.10.1038/bjc.2011.401Suche in Google Scholar PubMed PubMed Central

Wotschofsky, Z., Liep, J., Meyer, H.A., Jung, M., Wagner, I., Disch, A.C., Schaser, K.D., Melcher, I., Kilic, E., Busch, J., et al. (2012). Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas. Int. J. Biol. Sci. 8, 1363–1374.10.7150/ijbs.5106Suche in Google Scholar PubMed PubMed Central

Wu, D., Li, M., Wang, L., Zhou, Y., Zhou, J., Pan, H., and Qu, P. (2014). MicroRNA-145 inhibits cell proliferation, migration and invasion by targeting matrix metallopeptidase-11 in renal cell carcinoma. Mol. Med. Rep. 10, 393–398.10.3892/mmr.2014.2149Suche in Google Scholar PubMed

Yoshino, H., Enokida, H., Itesako, T., Kojima, S., Kinoshita, T., Tatarano, S., Chiyomaru, T., Nakagawa, M., and Seki, N. (2013). Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. Cancer Sci. 104, 1567–1574.10.1111/cas.12280Suche in Google Scholar PubMed PubMed Central